Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer

被引：3

作者：

Putora, P. M. ^{[1
]}

Benz, G. ^{[2
]}

Rodriguez, R. ^{[3
]}

Brutsche, M. ^{[2
]}

Frueh, M. ^{[4
]}

机构：

[1] Cantonal Hosp St Gallen, Dept Radiat Oncol, St Gallen, Switzerland

[2] Cantonal Hosp St Gallen, Dept Pneumol, St Gallen, Switzerland

[3] Cantonal Hosp St Gallen, Inst Pathol, St Gallen, Switzerland

[4] Cantonal Hosp St Gallen, Dept Oncol & Hematol, St Gallen, Switzerland

来源：

EUROPEAN RESPIRATORY JOURNAL | 2011年 / 38卷 / 05期

关键词：

EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; PARONYCHIA; INHIBITOR; GEFITINIB; THERAPY;

D O I：

10.1183/09031936.00008411

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：1228 / 1230

页数：4

共 9 条

[1]

[Anonymous], 2008, ENZINGER WEISSS SOFT

[2]

Bolognia J.L., 2007, Dermatology

[3] Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody [J].

Boucher, KW ;

Davidson, K ;

Mirakhur, B ;

Goldberg, J ;

Heymann, WR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) :632-633

[4] Complications of therapy in cancer patients - Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer [J].

Chang, GC ;

Yang, TY ;

Chen, KC ;

Yin, MC ;

Wang, RC ;

Lin, YC .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4646-4648

[5] Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor [J].

Dainichi, T ;

Tanaka, M ;

Tsuruta, N ;

Furue, M ;

Noda, K .

DERMATOLOGY, 2003, 207 (03) :324-325

[6] Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor [J].

Lee, MW ;

Seo, CW ;

Kim, SW ;

Yang, HJ ;

Lee, HW ;

Choi, JH ;

Moon, KC ;

Koh, JK .

ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) :23-26

[7] Paronychia induced by Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor [J].

Nakano, J ;

Nakamura, M .

JOURNAL OF DERMATOLOGY, 2003, 30 (03) :261-262

[8] Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors [J].

Segaert, S ;

Van Cutsem, E .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1425-1433

[9] EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients [J].

Tang, XN ;

Shigematsu, H ;

Bekele, BN ;

Roth, JA ;

Minna, JD ;

Hong, WK ;

Gazdar, AF ;

Wistuba, II .

CANCER RESEARCH, 2005, 65 (17) :7568-7572

← 1 →